|
blood draw Clinical Trials
2 actively recruiting trials across 1 location
▲ +1 trial since August 2026
Top Sponsors
- University of Alabama at Birmingham1
- University Hospital, Strasbourg, France1
Indications
- Primary Immunodeficiencies1
- ANCA Associated Vasculitis1
- Antiphospholipid Syndrome1
- Liver Disease1
- Systemic Scleroderma1
Other1 trial
Birmingham, Alabama1 trial
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
University of Alabama at Birmingham
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.